Novo Nordisk rolled out its first-ever direct-to-consumer (DTC) campaign for Ozempic on Monday, setting the stage for the once-weekly injectable Type 2 diabetes drug to take the spotlight.
The ad is set to the tune of the ’70s pop song “Magic,” but a clever change in the chorus replaces it with the drug’s name, Ozempic. It also features a twitchy earworm jingle for the GLP-1 drug that repeats several times throughout the commercial.
It’s Magic
The earworm-y jingle for Novo Nordisk’s Ozempic (semaglutide) is set to the music of the song “Magic,” by Scottish pop rock band Pilot. The drug is a once-weekly injection that has been shown to lower A1C levels and decrease the risk of heart disease in people with type 2 diabetes.
As the name suggests, Ozempic has also been shown to help weight loss. Some users lose 14 pounds and more when using it.
But despite all the benefits, it has a few drawbacks, including a high risk of addiction and nausea. That’s why comedian Chelsea Handler has come out against the drug.
Regardless of what it’s called, the drug is not for everyone. Some people may experience adverse effects or have allergic reactions. So if you’re considering trying it, be sure to consult your doctor first. Then, you can decide if it’s right for you! Alternatively, you can avoid it altogether. But if you do go ahead with the pill, be sure to do it safely and responsibly.
It’s Fast
A lot of this year’s Olympic competition has been held in China. The competition is intense, and the ozemical winner may be a long shot. But it is still fun to see the world’s best athletes competing in the name of sport. It’s also a great time to take in the sights and sounds of the city. You can also try your hand at some of the more exciting events, such as the Olympics’ opening ceremony. But for the most part, you’ll probably need a few days off work to get up to speed. The best way to do this is to keep the schedule on your mind, and don’t forget to eat a proper breakfast.
One of the most exciting developments to emerge from the whacky competition is Ozempic, a new entrant in the diabetes drug space that has taken the industry by storm. It’s the newest iteration of Novo Nordisk’s popular insulin goop. It’s actually a good bit of a marketing ploy: The company is promoting a small dose of the drug, and then selling you a bunch more. Using the latest in medical technology, it lowers blood sugar levels and has a surprisingly low cost to boot. It’s not for everyone, though, so it might be a smart move to seek out a plethora of reputable sources before making your next purchase.
It’s Easy
The ozempic song is easy to sing, and it’s a fun activity for kids. After learning the lyrics, have students act out different Olympic sports, choosing their own gestures and adding in adjectives describing each athlete’s abilities.
You can also play the music from “It’s Easy!” on a loop in your classroom. It’s a great song for kids to listen to while they learn about bullying, and it can be used to encourage empathy and kindness toward one another.
You might know the song from NBC’s coverage of the Olympics, but it wasn’t written for the games. It was composed by John Williams, whose music is known for its emotional power.
It’s Safe
A safe is a secure box or other item that is intended to protect valuables from harm. It is also a synonym for security in general.
A top of the line safe is a tad overpriced, but it does the job and keeps your treasures protected from prying eyes or thieves. It’s not for everyone, of course.
For the uninitiated, it was the ozempic of the many TV commercials that caught my attention. Novo Nordisk paired a hefty dose of hype with the elusive ad award for launching its first DTC campaign for Ozempic, the first prescription medicine in more than two decades to win a coveted FDA approval to lower blood sugar levels in Type 2 diabetics. The ad boasted a whopping $32 million budget for the 90-second spot, and has garnered more than 250 million hits on TikTok in the process. The ad is also the most viewed medical advertisement on Facebook in the US.